Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Frederic Colombel

Showing results (311-320 of 377) with videos related to

Pageof 38
Sort By:
Nature Immunology|July 30, 2024
A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycanJoana Gaifem, Cláudia S Rodrigues, Francesca Petralia, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialEdouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Gastroenterology|December 12, 2018
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative ColitisSudarshan Paramsothy, Shaun Nielsen, Michael A Kamm, et al.
The Lancet. Gastroenterology & Hepatology|April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial designSailish Honap, Nelly Agrinier, Joana Torres, et al.
Gastroenterology|May 7, 2020
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated DiseasesEli Stahl, Giulia Roda, Amanda Dobbyn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Defined microbiota transplant restores Th17/RORγt<sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotasGraham J Britton, Eduardo J Contijoch, Matthew P Spindler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Inflammatory Bowel Diseases|February 8, 2013
Quality indicators for inflammatory bowel disease: development of process and outcome measuresGil Y Melmed, Corey Allan Siegel, Brennan M Spiegel, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Archives of Iranian Medicine|February 7, 2022
Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD MedicationsAli Reza Sima, Bahar Saberzadeh-Ardestani, Homayoon Vahedi, et al.
Pageof 38

Showing results (311-320 of 377) with videos related to

Sort By:
Pageof 38
Nature Immunology|July 30, 2024
A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycanJoana Gaifem, Cláudia S Rodrigues, Francesca Petralia, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialEdouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Gastroenterology|December 12, 2018
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative ColitisSudarshan Paramsothy, Shaun Nielsen, Michael A Kamm, et al.
The Lancet. Gastroenterology & Hepatology|April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial designSailish Honap, Nelly Agrinier, Joana Torres, et al.
Gastroenterology|May 7, 2020
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated DiseasesEli Stahl, Giulia Roda, Amanda Dobbyn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Defined microbiota transplant restores Th17/RORγt<sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotasGraham J Britton, Eduardo J Contijoch, Matthew P Spindler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Inflammatory Bowel Diseases|February 8, 2013
Quality indicators for inflammatory bowel disease: development of process and outcome measuresGil Y Melmed, Corey Allan Siegel, Brennan M Spiegel, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Archives of Iranian Medicine|February 7, 2022
Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD MedicationsAli Reza Sima, Bahar Saberzadeh-Ardestani, Homayoon Vahedi, et al.
Pageof 38